Category: Diagnostics
New Zealand Diagnostics
-
2022 New Zealand Clinical Chemistry Market Supplier Shares - Competitive Analysis of Leading and Emerging Market Players
... analyzers and reagents, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. The companies profiled in the report include: Abbott Agilent Technologies Beckman Coulter/Danaher bioMerieux Bio-Rad ... Read More
-
2022-2026 New Zealand Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline
... Forecasts, Latest Technologies and Instrumentation Pipeline This new report from LeadingMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the clinical chemistry and immunodiagnostic markets during ... Read More
-
2022-2026 New Zealand Tumor Markers Testing Market High-Growth Opportunities for Cancer Diagnostic Tests and AnalyzersSupplier Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
... from LeadingMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends in the cancer diagnostics market; reviews current and ... Read More
-
2022-2026 New Zealand Genetic Diseases, Cancer, Forensic, Paternity Molecular Diagnostics Market Opportunities - Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Market Barriers and Risk
... designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities for molecular diagnostic technologies and products for diagnosing genetic diseases, cancer, as well as forensic and paternity/HLA testing during the next ... Read More